The approach I take to managing the Fidelity China Special Situations trust is to focus on undervalued companies that have good long-term growth prospects and have been underestimated by the wider market. The Chinese market is the perfect hunting ground for such stocks. It is broad with the winners still growing rapidly, and there are plenty of hidden gems that fly under the radars of local and international analysts.
I hone in on opportunities in small and medium-sized companies, where lower levels of research by the market leads to greater potential for mispricing, but I also invest in large or mega-cap companies, including state-owned enterprises, where mispricing appears. China’s capital markets are increasingly dynamic, with new firms coming to market all the time. We are finding more opportunities to take positions in companies before they go public. In recent years the private markets have deepened; more companies are finding it possible to fulfil their capital needs with more rounds of capital raising before they float. The trust is free to invest up to 15% of the portfolio in unlisted companies.
The portfolio’s focus remains on “New China” and the domestic economy, which is benefiting from the increase in wealth and size of the middle class. Covid-19 has accelerated structural trends already underway in China, such as the wider penetration and acceptance of e-commerce, which bodes well for growth industries such as IT and certain consumer-discretionary sectors.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Opportunity in volatility
In recent weeks volatility has returned to Chinese equities, driven by an extensive regulatory overhaul of the education sector. Over the past year industries such as mobile payments, fintech and e-commerce have also been subject to regulatory clampdowns. China is a policy-driven market and you need to accept bouts of market volatility. In fact, volatility can create opportunities to invest in high-quality companies at attractive valuations. I see the current environment as one of those times.
One of our holdings is WuXi AppTec (Shanghai: 603259), a global biopharmaceutical and medical-device company. It has benefited from ongoing strong global demand for contract research and manufacturing services. The company’s ability to grow its strong talent pool is a key strength. There is exciting potential from new technological developments in which the company continues to innovate, such as cell and gene therapy.
The newly rich need asset managers
A leading wealth and asset-management services provider, Noah Holdings (NYSE: NOAH), is a beneficiary of significant wealth growth and the increasing number of high net-worth individuals in China. Its core underlying strengths include trust from its client base in addition to its capable distribution team.
Given the low penetration in protection-type life insurance and expected demand growth given higher incomes, the insurance sector should see solid growth in the next few years. There could also be renewed demand post Covid-19 as people focus more on areas such as health insurance. China Pacific Insurance (Shanghai: 601601) is the sector’s third-largest company, comprising life, property and casualty divisions. I am also impressed by the management team’s new efforts to incentivise their workforce and boost productivity.
-
Barclays begins paying up to £100 compensation to customers after banking outageBarclays will pay up to £7.5 million in compensation to customers after its banking services were disrupted by an IT outage
-
Review: Shangri-La Paris – an ode to the world’s best foodNatasha Langan enjoys fine French and Chinese cuisine at the Shangri-La Paris
-
The star small and mid-cap stocks income investors have overlookedOpinion Thomas Moore, senior investment director, Aberdeen, highlights three company stocks as he shares where he would put his money
-
Falling revenues and mounting debt spell trouble for Jumia TechnologiesStruggling African e-commerce platform Jumia Technologies looks headed for the exit, says Dr Matthew Partridge.
-
Chemring Group: an explosive investment opportunity in defenceEuropean states are raising their military spending, and Chemring Group looks well placed to profit
-
Next reports £1 billion in annual profits for the first time – what's next for the retailer?Clothing retailer Next has become only the fourth member of its sector to surpass £1 billion in annual profits. What does this mean for the company's future?
-
Best of British bargains: cash in on undervalued companies in the UK stock marketOpinion Michael Field, Chief Equity Market Strategist, EMEA, Morningstar, selects three attractive UK stocks where he'd put his money
-
Building firm Keller presents low debt and ample scope for growthGeotechnical contractor Keller, which supports vital global infrastructure, boasts rising profits and a cheap valuation
-
PZ Cussons share price down 75% in last decade – why it's one to watchOpinion Once-strong consumer-goods business PZ Cussons is out of favour with the market. That spells opportunity for investors, says Jamie Ward
-
Cash in on the biotech sector with specialist trust BioPharmaOpinion BioPharma has an attractive niche in lending to asset-rich biotechnology companies
